These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4627319)

  • 41. Studies of thoracic duct lymphocytes of mice. II. A quantitative comparison of the capacity of thoracic duct lymphocytes and other lymphoid cells to induce graft-versus-host reactions.
    Cantor H; Mandel MA; Asofsky R
    J Immunol; 1970 Feb; 104(2):409-13. PubMed ID: 4391693
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 43. Graft-versus-host and cytotoxic activity of rat thoracic duct lymphocytes fractionated by zonal centrifugation after culture on allogeneic fibroblasts.
    Bowers WE
    J Immunol; 1974 Oct; 113(4):1252-61. PubMed ID: 4153365
    [No Abstract]   [Full Text] [Related]  

  • 44. The mediator of cellular immunity. XII. Inhibition of activated T cells by Newcastle disease virus.
    McGregor DD; Logie PS; Carmichael LE
    J Exp Med; 1976 Sep; 144(3):627-43. PubMed ID: 8579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for the quantitative measurement of cell aggregation.
    Deman J; Bruyneel E
    Exp Cell Res; 1973 Oct; 81(2):351-9. PubMed ID: 4758904
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on lymph humoral factor. Evidence for a lymphocytopoietic factor in rat thoracic duct lymph.
    Yamashita A; Fukumoto T; Miyamoto M
    Immunology; 1976 Mar; 30(3):349-59. PubMed ID: 1254321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring molecules of the plasma membrane: renewal of sialic acid-terminating receptors.
    Marcus PI; Schwartz VG
    Wistar Inst Symp Monogr; 1968; 8():143-51. PubMed ID: 5664322
    [No Abstract]   [Full Text] [Related]  

  • 48. Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells.
    Sprent J; Miller JF
    Cell Immunol; 1972 Mar; 3(3):385-404. PubMed ID: 5013309
    [No Abstract]   [Full Text] [Related]  

  • 49. Production of an immunoglobulin-binding factor (IBF) by antigen-stimulated lymph node lymphocytes.
    Fridman WH; Nelson RA; Liabeuf A
    J Immunol; 1974 Sep; 113(3):1008-16. PubMed ID: 4137896
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of neuraminidase treatment of ribosome-free membranes on their ribosomal reattachment ability.
    Scott-Burden T; Hawtray AO
    Biochem Biophys Res Commun; 1973 Oct; 54(4):1288-95. PubMed ID: 4356813
    [No Abstract]   [Full Text] [Related]  

  • 51. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues.
    Klinkert WE; LaBadie JH; Bowers WE
    J Exp Med; 1982 Jul; 156(1):1-19. PubMed ID: 6211498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perturbation of lymphocyte circulation in experimental murine leprosy. II. Nature of the defect.
    Bullock WE
    J Immunol; 1976 Oct; 117(4):1171-8. PubMed ID: 789768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte subpopulations in NZB mice: deficit of thymus-dependent lymphocytes.
    Stutman O
    J Immunol; 1972 Sep; 109(3):602-11. PubMed ID: 4538300
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphocyte recognition of lymph node high endothelium. III. Enhancement by a component of thoracic duct lymph.
    Carey GD; Chin YH; Woodruff JJ
    J Immunol; 1981 Sep; 127(3):976-9. PubMed ID: 7021679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specificity of xenoantisera against mouse cell surface antigens.
    Chen CH; Sabbadini E; Sehon AH
    Transplantation; 1974 Jan; 17(1):22-9. PubMed ID: 4543679
    [No Abstract]   [Full Text] [Related]  

  • 56. The migration of lymphocytes across specialized vascular endothelium. II. The contrasting consequences of treating lymphocytes with tryspin or neuraminidase.
    Ford WL; Sedgley M; Sparshott SM; Smith ME
    Cell Tissue Kinet; 1976 Jul; 9(4):351-61. PubMed ID: 1277266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assays for cellular antigens in the presence of detergents.
    Williams AF
    Eur J Immunol; 1973 Oct; 3(10):628-32. PubMed ID: 4203062
    [No Abstract]   [Full Text] [Related]  

  • 58. A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.
    Kendal AP
    Virology; 1975 May; 65(1):87-99. PubMed ID: 49979
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the hemagglutination phenomenon of hemagglutinating encephalomyelitis virus (HEV) of pigs.
    Greig AS; Bouillant AM
    Can J Comp Med; 1972 Oct; 36(4):366-70. PubMed ID: 4263916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Density distribution analysis of lymphocyte populations.
    Shortman K; Haskill JS; Szenberg A; Legge DG
    Nature; 1967 Dec; 216(5121):1227-8. PubMed ID: 6076076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.